⌘K

Home/Filings/4/0001516551-25-000004

4//SEC Filing

Arora Puneet S. 4

Accession 0001516551-25-000004

CIK 0001516551other

View on SEC.gov Company Profile

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 5:34 PM ET

Size

5.6 KB

Accession

0001516551-25-000004

Insider Transaction Report

Form 4

Period: 2025-02-24

Skye Bioscience, Inc.SKYE

Arora Puneet S.

Chief Medical Officer

Transactions

Award
Stock Option (Right to Buy)
2025-02-24+38,000→ 38,000 total
Exercise: $2.89Exp: 2035-02-25→ Common Stock (38,000 underlying)

Footnotes (1)

[F1]The stock option vests 25% on the one year anniversary of February 21, 2025 and 1/48th monthly thereafter.

Documents

1 file

4
wk-form4_1740609251.xmlPrimary
FORM 4

Issuer

Skye Bioscience, Inc.

CIK 0001516551

Entity typeother

Related Parties

1

filerCIK 0002035933

Filing Metadata

Form type: 4
Filed: Feb 25, 7:00 PM ET
Accepted: Feb 26, 5:34 PM ET
Size: 5.6 KB

View on SEC.gov